Equity / Investment · GCC · Announced 1 Nov 2026
Aram Pharma → Salalah Free Zone
Salalah Free Zone signed an MoU with Aram Pharma for a pharmaceutical secondary-packaging project, part of a wider Omani push to build pharma clusters in three zones.
Parties: Aram Pharma → Salalah Free Zone (Oman)
- Deal type
- Equity / Investment
- Value
- Undisclosed
- Territory
- Salalah Free Zone, Oman
- Therapeutic area
- Other
- Asset
- Secondary packaging of pharmaceutical products
- Announced
- 1 Nov 2026
Our analysis
Why this matters
On 1 November 2026, Oman's Public Authority for Special Economic Zones and Free Zones announced pharmaceutical and medical-device clusters in three zones: Salalah Free Zone, Risut Industrial City and Khazaen Economic City. At the event, Salalah Free Zone signed two memoranda of understanding. One, with Aram Pharma, covers a project specialised in secondary packaging of pharmaceutical products. The other, with Apex Trans Gulf Manufacturing, covers medical devices. Reported figures put the two MoUs at OMR 30.76 million over 50,000 square metres, but the report does not state Aram's share.
The clusters offer customs exemptions, a 50-year usufruct, up to 30-year tax and financial exemptions and 100% foreign ownership.
The full analysis is free to read with a work email on this page.
Source: Al Roya (Oman)